Back
Danaher Corporation (DHR)
Life Sciences Tools & ServicesDHR · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$199.02
+1.63%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$5.05
ROE
7.1%
Gross margin
59.0%
Debt/Equity
0.37x
Revenue growth
3.7%
Danaher Corporation — company intelligence
Earnings surprises
Q1 2026$2.06 vs $1.96 est+5.3%
Q4 2025$2.23 vs $2.17 est+2.6%
Q3 2025$1.89 vs $1.74 est+8.7%
Q2 2025$1.80 vs $1.66 est+8.4%
Insider activity · 90 days
23 buys2 sellsnet +18,561 shares
Zerhouni Elias A.Buy 1,699 · May 15, 2026
List TeriBuy 1,699 · May 15, 2026
Sanders A ShaneBuy 680 · May 15, 2026
Recent SEC filings
8-K — Material event reportJun 3, 2026
4 — Insider transaction reportMay 19, 2026
4 — Insider transaction reportMay 19, 2026
Latest news
Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment — Yahoo · 16h ago
Danaher Is Getting Better, But The Stock Still Isn't Cheap — SeekingAlpha · 17h ago
Jim Cramer on Danaher: “I Don’t Want You Anywhere Near That One” — Yahoo · 23h ago
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover — Benzinga · 1d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Danaher Corporation
Weekly undervalued picks (like DHR)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.